Author: David-Levine

Covid-19 Trade Secrets and Information Access: An Overview

[David Levine] The unprecedented Covid-19 (Covid) virus has brought to the forefront many challenges associated with exclusive rights, information sharing, and innovation. How do we get effective diagnostics, treatments and vaccines quickly and safely to the public? More specifically, how do we ensure that sufficient quantities are produced, that health products are affordable, and that they are equitably distributed globally? Among many challenges on the road to this outcome is the difficult question of how to handle trade secrets, namely, information that is valuable because others do not know it… For the public at large, Covid trade secrets raise two primary issues: (a) When do you have a Covid trade secret, and (2) Should access to that trade secret extend to competitors, civil society groups, and/or the public? Both are challenging questions, and the below presents a general overview of the framework for addressing each question.

Read More

WikiLeaks and the Control of Public Debate

“If you want to kill a trade agreement, or any effort to make new law or policy, keep it secret for an excessive amount of time and leave the timing of its eventual release to the law or policy’s skeptics and enemies.”  That...

Read More

Follow

Facebook     Twitter

PIJIP

infojustice.org is  hosted by the Program on Information Justice and Intellectual Property at American University Washington College of Law.

Infojustice Roundup

Free to Share

RSS Comments on:

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Civil Society Documents

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Comments on:

  • An error has occurred, which probably means the feed is down. Try again later.